CTRI/2014/01/004276招募中3 期
Role of PET/CT in assessment of metabolic response of neoadjuvant chemoradiotherapy in patients with carcinoma esophagus
All India Institute of Medical Sciences New Delhi0 个研究点目标入组 50 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Age < 65 years
- •2.Squamous cell carcinoma
- •3.Good performance status (Eastern Cooperative Oncology Group [ECOG] grades 0, 1 and 2)
- •4. Contrast enhanced computerized tomographic (CECT) scan suggesting a potentially resectable lesion. The features of resectability assessed on CECT scan will include - no evidence of infiltration of mediastinal structures such as the aorta (angle of contact <90°, no obliteration of the triangular fat space between the esophagus, aorta, and spine), and pericardium, and no evidence of tracheobronchial fistula or tumor extension into the airway lumen.
- •5.No evidence of distant metastasis on CECT.
排除标准
- •1.Comorbid conditions which would preclude esophagectomy
- •Poor performance status (ECOG > 2)
- •American Society of Anesthesiologists class IV
- •2.Metastatic disease detected on evaluation
- •3.Involvement of mediastinal structures
- •4.Carcinoma involving cervical esophagus
- •5.Previous radiotherapy or chemotherapy
研究者
相似试验
进行中（未招募）
不适用
PET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical TreatmentColorectal Cancer Stage IVNCT02618850National Cancer Institute, Naples260
进行中（未招募）
不适用
PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First ChemotherapyNon-small Cell Lung Cancer MetastaticNon-small Cell Lung Cancer Stage IIIBNCT02035683National Cancer Institute, Naples220
已完成
不适用
Metabolic Anomolies Associated With the 6 Month Clinical Evolution of Patients Suffering From Motor Conversion DisorderConversion DisorderNCT02329626Centre Hospitalier Universitaire de Nīmes20
尚未招募
Unknown
Correlation of PET CT reesponse and post surgery and chemotherapy biopsy response in lung cancer patientsCTRI/2024/02/063096AIIMS New Delhi
Unknown
不适用
Molecular PET/MR Imaging in Vivo Validation of Biomarker for Human Prostate CancerProstate AdenocarcinomaNCT03451812Chang Gung Memorial Hospital120